Thibaut Roulon
Director/Miembro de la Junta en NH THERAGUIX SAS .
Origen de la red de primer grado Thibaut Roulon.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
80
| Subsidiary | Investment Managers | 80 |
21
| Public Company | Pharmaceuticals: Generic | 21 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.
12
| Holding Company | Pharmaceuticals: Major | 12 |
| Holding Company | Pharmaceuticals: Major | 12 | |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France.
5
| Subsidiary | Medical Specialties | 5 |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018.
5
| Holding Company | Medical Specialties | 5 |
Bioam Gestion SA
 Bioam Gestion SA Investment ManagersFinance Bioam Gestion SA (BG) is a venture capital investment firm established in 2000 at the initiative of the French Ministry of Research and located in Paris. The firm invests capital from public and private sources. BG manages FCPR venture capital funds focused on the biotechnology sector. The firm's sponsors include the three French national research institutes: CNRS (fundamental research), INRA (agriculture-oriented research) and INSERM (medical research), as well as financial institutions such as CDC Enterprises, AXA Private Equity, a regional savings bank, and corporations.
2
| Extinct | Investment Managers | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Thibaut Roulon a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
CDC Enterprises, Inc.
 CDC Enterprises, Inc. Electrical ProductsProducer Manufacturing CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL. | Electrical Products | Chairman Chief Investment Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Director/Board Member Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
| INTEGRAGEN | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Founder | |
| EOS IMAGING | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Investor | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
UroMems SAS
 UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| MERSEN | Electrical Products | Director/Board Member Director/Board Member Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Corporate Officer/Principal Chief Executive Officer | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Sciences Po | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Consolidation & Développement Gestion SAS
 Consolidation & Développement Gestion SAS Investment ManagersFinance Consolidation & Développement Gestion SAS (Consolidation Dev Gestion) is a private equity firm headquartered in paris, France. It was founded in 2009 and is a subsidary of BPIFrance Investissement SAS. | Investment Managers | Chairman Private Equity Analyst | |
| NEXANS | Electrical Products | Director/Board Member Director/Board Member | |
| DEINOVE | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Keranova SA
 Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| BIOM'UP | Medical Specialties | Director/Board Member Director/Board Member | |
Diabeloop SAS
 Diabeloop SAS Medical SpecialtiesHealth Technology Diabeloop SAS develops an electronic artificial pancreas for patients suffering from diabetes 1 in order to reduce hypoglycemia. The company was founded on March 24, 2015 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Chairman | |
Mexbrain SAS
 Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Medical Specialties | Director/Board Member Founder | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| THERANEXUS | Pharmaceuticals: Major | Director/Board Member Chairman | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Gimv (Private Equity)
 Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium. | Investment Managers | Director/Board Member Private Equity Investor | |
| University of Geneva | College/University | Graduate Degree Doctorate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Bpifrance SA
 Bpifrance SA Finance/Rental/LeasingFinance Bpifrance SA provides aids and financial support to small and medium companies. Its solutions include loans, insurance, warranties, and equity investments. The creation of the BPI was formalized by Law no. 2012-1559 on 31 December 2012, amending Ordinance no. 2005-722 of June 29, 2005, relating to the creation of the public institution OSEO, which became EPIC BPI-Groupe then EPIC Bpifrance, and the public limited company OSEO (now Bpifrance). The company was founded in 1923 and headquartered in Maisons-Alfort, France. | Finance/Rental/Leasing | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Francia | 42 |
| Estados Unidos | 4 |
| Bélgica | 3 |
| Suiza | 3 |
| Dinamarca | 2 |
Sectorial
| Health Technology | 29 |
| Consumer Services | 8 |
| Finance | 8 |
| Commercial Services | 4 |
| Producer Manufacturing | 4 |
Operativa
| Director/Board Member | 609 |
| Corporate Officer/Principal | 115 |
| Chairman | 91 |
| Private Equity Investor | 65 |
| Independent Dir/Board Member | 62 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Anne-Sophie Herelle | 65 |
| Raphaël Wisniewski | 45 |
| Vanessa Giraud | 41 |
| Célia Hart | 36 |
| Jérôme Gallot | 33 |
| Rémi Droller | 29 |
| Florent Gros | 28 |
| Chahra Khaoua Epouse Louafi | 26 |
| Hugues le Bret | 25 |
| Gérard Hascoët | 25 |
| Philippe Boucheron | 24 |
| Louis Joseph Nisbet | 24 |
| Jean-Michel Petit | 24 |
| Philippe Archinard | 24 |
| Catherine Dunand | 23 |
- Bolsa de valores
- Insiders
- Thibaut Roulon
- Conexiones Empresas
